Removal of iopromide and degradation characteristics in electron beam irradiation process

Department of Environmental Engineering (YIEST), Yonsei University, Heungup, Wonju, Republic of Korea.
Journal of hazardous materials (Impact Factor: 4.33). 05/2012; 227-228:126-34. DOI: 10.1016/j.jhazmat.2012.05.022
Source: PubMed

ABSTRACT The aim of this study is to evaluate the removal efficiency of iopromide using electron beam (E-beam) irradiation technology, and its degradation characteristics with hydroxyl radical (OH) and hydrated electron (e(aq)(-)). Studies are conducted with different initial concentrations of iopromide in pure water and in the presence of hydrogen peroxide, bicarbonate ion, or sulfite ion. E-beam absorbed dose of 19.6 kGy was required to achieve 90% degradation of 100 μM iopromide and the E-beam/H(2)O(2) system increased the removal efficiency by an amount of OH· generation. In the presence of OH scavengers (10 mM sulfite ion), the required dose for 90% removal of 100 μM iopromide was only 0.9 kGy. This greatly enhanced removal was achieved in the presence of OH· scavengers, which was rather unexpected and unlike the results obtained from most advanced oxidation process (AOP) experiments. The reasons for this enhancement can be explained by a kinetic study using the bimolecular rate constants of each reaction species. To explore the reaction scheme of iopromide with OH· or e(aq)(-) and the percent of mineralization for the two reaction paths, the total organic carbon (TOC), released iodide, and intermediates were analyzed.

Download full-text


Available from: Minhwan Kwon, Jun 30, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The main objective of this study was to conduct an exhaustive review of the literature on the presence of pharmaceutical-derived compounds in water and on their removal. The most representative pharmaceutical families found in water were described and related water pollution issues were analyzed. The performances of different water treatment systems in the removal of pharmaceuticals were also summarized. The water treatment technologies were those based on conventional systems (chlorine, chlorine dioxide, wastewater treatment plants), adsorption/bioadsorption on activated carbon (from lotus stalks, olive-waste cake, coal, wood, plastic waste, cork powder waste, peach stones, coconut shell, rice husk), and advanced oxidation processes by means of ozonation (O3, O3/H2O2, O3/activated carbon, O3/biological treatment), photooxidation (UV, UV/H2O2, UV/K2S2O8, UV/TiO2, UV/H2O2/TiO2, UV/TiO2/activated carbon, photo-Fenton), radiolysis (e-Beam, (60)Co, (137)Cs. Additives used: H2O2, SO3(2-), HCO3(-), CH3OH, CO3(2-), or NO3(-)), and electrochemical processes (Electrooxidation without and with active chlorine generation). The effect of these treatments on pharmaceutical compounds and the advantages and disadvantages of different methodologies used were described. The most important parameters of the above water treatment systems (experimental conditions, removal yield, pharmaceutical compound mineralization, TOC removal, toxicity evolution) were indicated. The key publications on pharmaceutical removal from water were summarized.
    Chemosphere 09/2013; 93(7). DOI:10.1016/j.chemosphere.2013.07.059 · 3.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The electron beam (EB) radiolysis characteristics of carbamazepine (CBZ) in pure-water with different ions and that in surface water were studied in this paper. It suggested that the ·OH, ·H and e aq− all played roles on CBZ EB degradation, and the ·OH played the vital role. Acidic solution was favorable for CBZ degradation, while alkaline environment inhibited it. HSO4– and SO32− enhanced the CBZ degradation, but CO32−, NO2−, NO3− NH4+ and Cl− inhibited. In surface water, the EB-radiolysis was an effective way to degrade CBZ; and CBZ might evolve in three different ways during EB radiation: reduction by e aq− and ·H (intermediate 10,11-dihydrocarbamazepine (I)), oxidization by ·OH (intermediates 10,11-dihydro-10-11-expoxycarbamazepine (II) and 2(3)-hydroxycarbamazepine (III)) and hydration into 10,11-dihydro-10-hydroxycarbamazepine (IV) and finally the intermediates were all mineralized into CO2, H2O, N2 and NH4+. All the results contribute to study the EB-radiolysis of pharmaceuticals in surface water.
    Journal of Radioanalytical and Nuclear Chemistry 10/2014; 302(1):139-147. DOI:10.1007/s10967-014-3322-8 · 1.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The electrochemical degradation of six of the most widely used iodinated contrast media was investigated. Batch experiments were performed under constant current conditions using two DSA® electrodes (titanium coated with a proprietary and patented mixed metal oxide solution of precious metals such as iridium, ruthenium, platinum, rhodium and tantalum). The degradation removal never fell below 85% (at a current density of 64mA/cm(2) with a reaction time of 150min) when perchlorate was used as the supporting electrolyte; however, when sulphate was used, the degradation performance was above 80% (at a current density of 64mA/cm(2) with a reaction time of 150min) for all of the compounds studied. Three main degradation pathways were identified, namely, the reductive de-iodination of the aromatic ring, the reduction of alkyl aromatic amides to simple amides and the de-acylation of N-aromatic amides to produce aromatic amines. However, as amidotrizoate is an aromatic carboxylate, this is added via the decarboxylation reaction. The investigation did not reveal toxicity except for the lower current density used, which has shown a modest toxicity, most likely for some reaction intermediates that are not further degraded. In order to obtain total removal of the contrast media, it was necessary to employ a current intensity between 118 and 182mA/cm(2) with energy consumption higher than 370kWh/m(3). Overall, the electrochemical degradation was revealed to be a reliable process for the treatment of iodinated contrast media that can be found in contaminated waters such as hospital wastewater or pharmaceutical waste-contaminated streams. Copyright © 2014 Elsevier B.V. All rights reserved.
    Science of The Total Environment 11/2014; 506. DOI:10.1016/j.scitotenv.2014.10.115 · 4.10 Impact Factor
Show more